Mingxi Tang

Mingxi Tang


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2024 in Journal of Integrative Neuroscience
Verified
Journal Article
Open access
PDF file
YZYuan Zhang
Yuan Zhang
RTRui Tang
Rui Tang
ZHZhi-Min Hu
Zhi-Min Hu
XWXi-Hao Wang
Xi-Hao Wang
XGXia Gao
Xia Gao
MTMingxi Tang
Mingxi Tang
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impaired social interactions and verbal communication, accompanied by symptoms of restricted and repetitive patterns of behavior or interest. Over the past 30 years, the morbidity of ASD has increased in most areas of the world. Although the pathogenesis of ASD is not fully understood, it has been associated with over 1000 genes or genomic loci, indicating the importance and complexity of the genetic mechanisms involved. This review focuses on the synaptic pathology of ASD and particularly on genetic variants involved in synaptic structure and functions. These include SHANK, NLGN, NRXN, FMR1, and MECP2 as well as other potentially novel genes such as CHD8, CHD2, and SYNGAP1 that could be core elements in ASD pathogenesis. Here, we summarize several pathological pathways supporting the hypothesis that synaptic pathology caused by genetic mutations may be the pathogenic basis for ASD.

26 September 2023 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
RTRui Tang
Rui Tang
JLJing Luo
Jing Luo
XZXiaoxia Zhu
Xiaoxia Zhu
PMPengyu Miao
Pengyu Miao
HTHong Tang
Hong Tang
MTMingxi Tang
Mingxi Tang
Fibrosis is a common pathological process that must take place for multiple chronic liver diseases to develop into cirrhosis and liver cancer. Liver fibrosis (LF) is regulated by various cytokines and signaling pathways in its occurrence and development. Ferroptosis is an important mode of cell death caused by iron-dependent oxidative damage and is regulated by iron metabolism and lipid peroxidation signaling pathways. In recent years, numerous studies have shown that ferroptosis is closely related to LF. As the main material secreted by the extracellular matrix, hepatic stellate cells (HSCs) are a general concern in the development of LF. Therefore, targeting HSC ferroptosis against LF is crucial. This review describes the current status of treating LF by inducing HSC ferroptosis that would aid studies in better understanding the current knowledge on ferroptosis in HSCs and the future research direction in this field.

15 February 2014
Verified
Journal Article
Closed access
YLYong Liu
Yong Liu
JZJie Zhou
Jie Zhou
CZCuiwei Zhang
Cuiwei Zhang
WFWenguang Fu
Wenguang Fu
XXXiuli Xiao
Xiuli Xiao
MTMingxi Tang
Mingxi Tang

7 December 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
RTRui Tang
Rui Tang
HWHaitao Wang
Haitao Wang
MTMingxi Tang
Mingxi Tang
Non-small cell lung cancer (NSCLC) is the most common and lethal type of lung cancer, with limited treatment options and poor prognosis. Immunotherapy offers hope for improving the survival and quality of life of NSCLC patients, but its efficacy depends on the tumor immune microenvironment (TME). Tissue-resident immune cells are a subset of immune cells that reside in various tissues and organs, and play an important role in fighting tumors. In NSCLC, tissue-resident immune cells are heterogeneous in their distribution, phenotype, and function, and can either promote or inhibit tumor progression and response to immunotherapy. In this review, we summarize the current understanding on the characteristics, interactions, and roles of tissue-resident immune cells in NSCLC. We also discuss the potential applications of tissue-resident immune cells in NSCLC immunotherapy, including immune checkpoint inhibitors (ICIs), other immunomodulatory agents, and personalized cell-based therapies. We highlight the challenges and opportunities for developing targeted therapies for tissue-resident immune cells and optimizing existing immunotherapeutic approaches for NSCLC patients. We propose that tissue-resident immune cells are a key determinant of NSCLC outcome and immunotherapy response, and warrant further investigation in future research.

1 May 2006 in Cancer Letters
Verified
Journal Article
Closed access
KOKumiko Ogawa
Kumiko Ogawa
MMMitsuko Masutani
Mitsuko Masutani
KKKoji Kato
Koji Kato
MTMingxi Tang
Mingxi Tang
NKNobuo Kamada
Nobuo Kamada
TSTomoyuki Shirai
Tomoyuki Shirai

1 September 2023 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
YLYongyi Li
Yongyi Li
MZMingwei Zhu
Mingwei Zhu
WCWen-Xiong Chen
Wen-Xiong Chen
JLJing Luo
Jing Luo
XLXin Li
Xin Li
YTYAPING TANG
YAPING TANG
Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders with a strong genetic liability. Despite extensive studies, however, the underlying pathogenic mechanism still remains elusive. In the present study, we identified a homozygous mutation in the intron 1 of Wnt1 via large-scale screening of ASD risk/causative genes and verified that this mutation created a new splicing donor site in the intron 1, and consequently, a decrease of WNT1 expression. Interestingly, humanized rat models harboring this mutation exhibited robust ASD-like behaviors including impaired ultrasonic vocalization (USV), decreased social interactions, and restricted and repetitive behaviors. Moreover, in the substantia nigra compacta (SNpc) and the ventral tegmental area (VTA) of mutant rats, dopaminergic (DAergic) neurons were dramatically lost, together with a comparable decrease in striatal DAergic fibers. Furthermore, using single-cell RNA sequencing, we demonstrated that the decreased DAergic neurons in these midbrain areas might attribute to a shift of the boundary of the local pool of progenitor cells from the hypothalamic floor plate to the midbrain floor plate during the early embryonic stage. Moreover, treatments of mutant rats with levodopa could attenuate the impaired USV and social interactions almost completely, but not the restricted and repetitive behaviors. Our results for the first time documented that the developmental loss of DAergic neurons in the midbrain underlies the pathogenesis of ASD, and that the abnormal progenitor cell patterning is a cellular underpinning for this developmental DAergic neuronal loss. Importantly, the effective dopamine therapy suggests a translational significance in the treatment of ASD.